Press Release: Recommendation to restrict the use of Protelos/Osseor (strontium ranelate)

Author (Corporate)
Series Title
Series Details EMA/258269/2013 (26.04.13)
Publication Date 26/04/2013
Content Type

The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP), on 25 April 2013, recommended a restriction in the use of the osteoporosis medicine Protelos/Osseor, following an assessment of data showing an increased risk of serious heart problems.
Source Link http://www.emea.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2013/04/news_detail_001774.jsp&mid=WC0b01ac058004d5c1
Related Links
EMA: Press Release: EMA/258269/2013 (26.04.13): Recommendation to restrict the use of Protelos/Osseor (strontium ranelate) http://www.emea.europa.eu/docs/en_GB/document_library/Press_release/2013/04/WC500142507.pdf
Subject Categories
Countries / Regions